Prøve GULL - Gratis

Labour codes: Standardising compliance for life sciences sector

Bio Spectrum

|

February 2026

The Government has consolidated 29 labour laws into four comprehensive Labour Codes. This move for across sectors is being seen as labour-friendly; however, a certain section of society seems to be wary. Experts from the life sciences sector welcome the new move on one hand, but express concern about the likely challenges.

- Sanjiv Das

Labour codes: Standardising compliance for life sciences sector

The Government of India has announced the implementation of the four Labour Codes in November 2025. The laws, the Code on Wages, 2019; the Industrial Relations Code, 2020; the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (OSH) came into effect from November 21, 2025, rationalising 29 existing labour laws. The implementation of the four Labour Codes comes at a time when there has been a hue and cry over malpractices being followed by companies. News of mass layoffs is nothing new, and for an employee, it has far-reaching impacts when it comes to mental stress and agony.

imageThe need for the labour law

Many of India’s labour laws were framed in the pre-Independence and early post-Independence era (1930s—1950s). This was at a time when the economy and world of work were fundamentally different. While most major economies have updated and consolidated their labour regulations in recent decades, India continued to operate under fragmented, complex and in several parts outdated provisions spread across 29 Central labour laws. These restrictive frameworks struggled to keep pace with changing economic realities and evolving forms of employment, creating uncertainty and increasing compliance burden for both workers and industry.

How will it impact the life sciences sector?

FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum

Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr

Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC

Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

PM launches Ayush Mark, setting global quality benchmarks for India's traditional medicine

In a historic and visionary move that marks a defining moment for India's traditional medicine ecosystem, Prime Minister (PM) Narendra Modi has launched the Ayush Mark, establishing a globally aligned quality certification framework for Ayush products and services.

time to read

1 min

February 2026

Bio Spectrum

Novo Nordisk launches world's most prescribed GLP-1 drug Ozempic in India

Novo Nordisk, a global healthcare company, has announced the launch of Ozempic (injectable semaglutide) in India.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Symbiotec Pharmalab files DRHP with SEBI for IPO aggregating upto Rs 2180 Cr

Indore-based Symbiotec Pharmalab, a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms-organic chemistry, biotechnology and complex injectables, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Centre announces special dispensation to deep-tech startups in DSIR accreditation process

Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh has announced a major relaxation in the mandatory three-year survival condition for deep-tech startups to get recognition under the Industrial R&D Promotion Programme of Department of Scientific and Industrial Research (DSIR).

time to read

1 min

February 2026

Bio Spectrum

Kashiv BioSciences secures Rs 648 Cr financing from UBI

Kashiv BioSciences, a biopharmaceutical company, has secured financing of Rs 648 crore from the Union Bank of India.

time to read

1 min

February 2026

Bio Spectrum

S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat

The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Senores Pharmaceuticals makes Rs 91 Cr acquisition of Apnar Pharma

Senores Pharmaceuticals has entered into a definitive agreement to acquire 100 per cent equity stake in Apnar Pharma, along with the acquisition of five Abbreviated New Drug Applications (ANDAs), marking a significant milestone in Senores' growth strategy across regulated pharmaceutical markets.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Intas Pharmaceuticals collaborates with IntegriMedical

Ahmedabad-based Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India's first NeedleFree Injection System (N-FIS), to introduce this revolutionary technology for use in IVF and gynaecology treatments across India. This marks a significant milestone in IVF and women's health.

time to read

1 min

February 2026

Listen

Translate

Share

-
+

Change font size